We are live on
!
Find out more
CCMD
Cypress Capital Management (Delaware) Portfolio holdings
AUM
$539M
1-Year Est. Return
11.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.01%
1 Year Est. Return
-11.57%
3 Year Est. Return
+25.57%
5 Year Est. Return
+49.47%
10 Year Est. Return
–
AUM
$287M
AUM Growth
–
Cap. Flow
+$288M
Cap. Flow
% of AUM
100.52%
Top 10 Holdings %
Top 10 Hldgs %
42.37%
Holding
45
New
45
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.5M |
| 2 |
AT&T
T
|
+$13.2M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$12.7M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$12.5M |
| 5 |
Verizon
VZ
|
+$12.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.28% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Technology | 12.91% |
| 4 | Energy | 9.16% |
| 5 | Communication Services | 8.74% |
Similar funds
KPW
SIMS
RTS
KCM
MG
SMG
HPWM
RWA
Cypress Capital Management (Delaware)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cypress Capital Management (Delaware), which disclosed 45 positions worth $287M. Its ten largest holdings account for 42% of the portfolio.
Its largest position is Pfizer: 488,638 shares worth $13M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Consumer Discretionary and Technology.
- Cypress Capital Management (Delaware)'s largest Q2 2013 buy was Pfizer: 488,638 shares worth $13M.
- Cypress Capital Management (Delaware)'s ten largest holdings make up 42% of its $287M portfolio in Q2 2013.
- Cypress Capital Management (Delaware) disclosed 45 positions in Q2 2013, its first 13F filing on record.
Based on Cypress Capital Management (Delaware)'s 13F filing for Q2 2013, filed 14 Aug 2013.